← Eichor
Study identifier: NCT06988618 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults

Condition: Prurigo Nodularis  ·  Sponsor: Galderma R&D

PhaseN/A
Planned participants600
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The main aim of this study is to assess real-world effectiveness of nemolizumab in Prurigo nodularis (PN) as measured by investigator and patient reported outcome (PRO) in clinical practice at Month 6.

This description comes directly from the study's public registry record.

Talk to the study team

Galderma Research and Development  ·  817-961-5000  ·  clinical.studies@galderma.com

Always discuss trial participation with your own doctor first.

Locations (51)

Galderma Investigational Site # 8893Birmingham, Alabama, United StatesNot Yet Recruiting
Galderma Investigational Site # 7077Phoenix, Arizona, United StatesNot Yet Recruiting
Galderma Investigational Site # 7060Phoenix, Arizona, United StatesNot Yet Recruiting
Galderma Investigational Site # 7067Tucson, Arizona, United StatesNot Yet Recruiting
Galderma Investigational Site # 7074Corona, California, United StatesNot Yet Recruiting
Galderma Investigational Site # 6836Fountain Valley, California, United StatesRecruiting
Galderma Investigational Site # 8224Fremont, California, United StatesNot Yet Recruiting
Galderma Investigational Site # 7064Santa Monica, California, United StatesNot Yet Recruiting
Galderma Investigational Site # 7061Castle Rock, Colorado, United StatesNot Yet Recruiting
Galderma Investigational Site # 7059Fairfield, Connecticut, United StatesNot Yet Recruiting
Galderma Investigational Site # 7087Coral Gables, Florida, United StatesNot Yet Recruiting
Galderma Investigational Site # 7063Cutler Bay, Florida, United StatesNot Yet Recruiting

+ 39 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06988618